Juan-jose Garces
Pamplona, NC 00489, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.
Journal: bioRxiv : the preprint server for biology
Published: December 19, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 08, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.
Journal: Cancer discovery
Published: June 24, 2025
Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.
Journal: Blood cancer discovery
Published: March 28, 2025
Genetic evidence against clonotypic B-lymphocytes as reservoir of plasma-cell cancers.
Journal: Blood cancer discovery
Published: March 28, 2025
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 13, 2025
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Journal: British journal of haematology
Published: January 20, 2023
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 31, 2022
Reply to I.V. Kostopoulos et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2022
Last Updated: 09/26/2026